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Abstract
Background: West Nile virus (WNV) infection can cause severe meningitis and encephalitis in
humans. Apoptosis was recently shown to contribute to the pathogenesis of WNV encephalitis.
Here, we used WNV-infected glioma cells to study WNV-replication and WNV-induced apoptosis
in human brain-derived cells.
Results:  T98G cells are highly permissive for lytic WNV-infection as demonstrated by the
production of infectious virus titre and the development of a characteristic cytopathic effect. WNV
replication decreased cell viability and induced apoptosis as indicated by the activation of the
effector caspase-3, the initiator caspases-8 and -9, poly(ADP-ribose)polymerase (PARP) cleavage
and the release of cytochrome c from the mitochondria. Truncation of BID indicated cross-talk
between the extrinsic and intrinsic apoptotic pathways. Inhibition of the caspases-8 or -9 inhibited
PARP cleavage, demonstrating that both caspases are involved in WNV-induced apoptosis. Pan-
caspase inhibition prevented WNV-induced apoptosis without affecting virus replication.
Conclusion: We found that WNV infection induces cell death in the brain-derived tumour cell
line T98G by apoptosis under involvement of constituents of the extrinsic as well as the intrinsic
apoptotic pathways. Our results illuminate the molecular mechanism of WNV-induced neural cell
death.
Background
West Nile Virus (WNV), a single stranded RNA flavivirus,
is a member of the Japanese encephalitis virus (JEV) sero-
complex. Initially isolated in 1937, it has become
endemic in Africa, the Middle East and parts of Asia and
Europe [1,2]. WNV infection of humans typically results
in subclinical or non-specific, mild febrile illnesses. How-
ever, about 1 in 150 patients will develop encephalitis and
meningitis with high lethality rate due to virus invasion
into the central nervous system (CNS) [3]. Since 1999, the
virus has increasingly gained importance in North Amer-
ica as it caused an epizootic among birds and horses and
an epidemic of meningitis and encephalitis in humans
[3]. To date, no pharmacological treatment options for
WNV-infected patients exist.
Apoptosis is a highly conserved mode of programmed cell
death, commonly mediated by the activation of caspases
[4]. Although neurons are regarded as the major target of
WNV in vivo [1], WNV infection has been shown to
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induce apoptosis in different cell lines in a similar manner
in vitro [5-8]. This includes a wide range of different cell
types such as mouse fibroblasts (NIH/3T3), mouse neu-
roblastoma cells (Neuro-2A), mouse embryonic stem
cells, Vero cells (African green monkey kidney cell line),
human ovarian carcinoma cells (HeLa), human neurob-
lastoma cells (SH-SY5Y), leukemic cells (K562), and
human rhabdomyosarcoma cells (RD) [5-9]. Different
WNV proteins (i.e. envelope 1 (E) and non-structural pro-
tein 3 (NS3)) were shown to induce caspase-dependent
apoptosis when transfected into cells [7,8]. Analysis of the
influence of WNV infection on the gene expression of
A172 (human glioma) cells using microarray technique
indicated upregulation of apoptosis-related genes [10].
Although neural cells were used, no further evaluation of
the distinct mechanism of cell death was performed.
Recently, it was shown that WNV-infection induces cas-
pase-3 activation and apoptosis in brains of wild-type
mice and in primary CNS-derived mouse neurons [11].
Both, caspase-3-/- genotype as well as treatment with cas-
pase inhibitors decreased virus-induced cell death. How-
ever, role of upstream apoptosis pathways was not
studied.
WNV infection-induced cell death may contribute to fatal
WNV disease [11,12]. Therefore, thorough knowledge of
the molecular mechanism of WNV-induced neural cell
death will allow us to better understand the progression of
WNV infection and the associated neurological pathol-
ogy. Here, we used human glioma cell line T98G that is
highly susceptible to WNV-induced apoptosis to investi-
gate the contribution of caspase-dependent apoptosis to
WNV infection-induced cell death. The potential of cas-
pase inhibitors to increase viability of WNV-infected cell
cultures was examined.
Results
Virus growth
When T98G cell cultures were infected at MOI 0.1 infec-
tious virus titres increased from undetectable levels at 1 h
p.i. to a maximum of 1.54 × 106 TCID50/ml at 48 h p.i.
(Fig. 1a). Infection at MOI 1 resulted in 24.5-fold (3.36 ×
106 vs. 1.37 × 105) and 6.4-fold (9.92 × 106 vs. 1.54 × 106)
higher infectious titres 24 and 48 h p.i. relative to cultures
infected at MOI 0.1. Both infectious virus titres of cultures
infected at MOI 0.1 and MOI 1 rapidly decreased after
reaching their maximum and were similar at 72 h (2.97 ×
105 vs. 3.36 × 105) and 96 h (1.15 × 104 vs. 1.49 × 104) p.i.
In contrast to decreasing infectious virus titres after a max-
imum at 48 h p.i., intracellular virus E protein accumu-
lated in the infected cells as shown by Western Blot
analysis (Fig. 1b).
Induction of cytopathic effect (CPE)
In T98G cells infected at MOI 1, first signs of a character-
istic CPE appeared 24 h p.i. impressing as rounding of the
cells and detachment from the monolayer. The intensity
of CPE increased with time and was highly noticeable at
72 h p.i. (Fig. 2a). In cultures infected at MOI 0.1 occur-
rence of CPE was delayed by approximately 24 h relative
to cultures infected at MOI 1 (data not shown).
WNV infection reduces cell viability and induces PARP 
cleavage in T98G cells
WNV infection markedly decreased cell viability of T98G
cells in a time dependent manner as measured by MTT
assay (Fig. 2b). This loss of viability was also dependent
on the MOI at which the cultures were infected. At 96 h
p.i. cell viability of WNV-infected cultures decreased to
34.9 and 50.2% when infected at MOI 1 and 0.1 respec-
tively. To show whether WNV-induced cell death was due
to apoptosis quantitative analysis of PARP cleavage into
proteolytic fragments was performed. At 48 h p.i. the
amount of cells that stained for the 85 kD fragment of
PARP was 18.17-fold higher than that of the mock
infected control. Induction of apoptosis depended on
viral replication as inactivated WNV failed to induce PARP
cleavage (Fig. 2c).
T98G cells are permissive for WNV infection Figure 1
T98G cells are permissive for WNV infection. Production of 
infectious virus titres (A) and accumulation of viral envelope 
antigen (B) in T98G cell cultures infected with WNV at dif-
ferent time points p.i. Values represent the mean (± SD) of 
three different experiments. The blot shown is representa-
tive for a set of three different experiments.BMC Microbiology 2007, 7:49 http://www.biomedcentral.com/1471-2180/7/49
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WNV infection induces caspase activation and cytochrome 
c release in T98G cells
Western blots performed with protein extracts of WNV-
infected and mock-infected cultures at 24, 48, 72 and 96
h p.i. showed cleavage of the initiator caspases, caspase-9
and caspase-8 and truncation of BID in infected cells. A 54
kD band, representing full-length pro-caspase-8, was
detected in all the lysates of mock-infected cultures with
constant intensity. In WNV-infected cultures (MOI 1) this
band decreased in intensity and was below detectable
level at 96 h p.i. (Fig. 3a). A 37 kD band, corresponding to
the cleavage product of caspase-9, was absent in the pro-
tein lysates of mock-infected cultures but became appar-
ent in the protein lysates of cultures infected with WNV
(MOI 1) at 48, 72 and 96 h p.i. The intensity of this 37 kD
band increased with time (Fig. 3a). In all mock-infected
cultures a 22 kD band representing full-length BID was
detected with constant intensity. In WNV-infected cul-
tures this band intensity decreased, indicating BID trunca-
tion during WNV-infection (Fig. 3a).
Quantification of cytochrome c release showed that at 24
h p.i. 6.5% of the WNV infected cells (MOI 1) did not
stain for mitochondrial cytochrome c compared to 2.5%
of the mock infected control. The amount of negative cells
increased to 10.99 and 15.52% at 48 and 72 h p.i., respec-
tively in WNV-infected cells compared to 1.96 and 5.51%
of the mock infected control (Fig. 3b). Activation of cas-
pase-3 was additionally quantified by immune-staining of
infected cells. At 48 h p.i. 11.3% of the cells infected with
WNV (MOI 1) stained for cleaved caspase-3 compared to
1.2% of the mock infected control. This amount increased
to 23.7% at 72 h p.i. compared to 2.3% of the mock
infected control (Fig. 3c).
Inhibition of WNV-induced PARP-cleavage by caspase 
inhibitor peptides
Virus-induced PARP cleavage was strongly inhibited when
caspase-8 inhibitor (z-IETD-fmk) caspase-9 inhibitor (z-
LEHD-fmk) and pan-caspase inhibitor (z-VAD-fmk) were
added directly to the cell culture medium of WNV-
infected cells (Fig. 4). All caspase inhibitors inhibited
PARP cleavage in a dose-dependent manner. Z-VAD-fmk
exerted the strongest inhibitory effects on PARP cleavage,
followed by z-IETD-fmk. However, addition of z-LEHD-
fmk resulted in the weakest inhibition of PARP cleavage.
Pan-caspase inhibition prevents WNV-induced cell death 
without affecting infectious virus titre production
The addition of 100 µM z-VAD-fmk directly to the cell cul-
ture medium of WNV-infected (MOI 0.1) T98G cell cul-
tures prevented virus-induced cell killing as assessed by
the trypan blue dye exclusion assay (Fig. 5a). To exclude
that this finding was an effect of altered viral replication
due to z-VAD-fmk treatment, virus-titres of WNV-infected
Effects of WNV on T98G cell viability Figure 2
Effects of WNV on T98G cell viability. WNV-induced CPE 
(MOI 1) (A), cell viability of WNV-infected T98G cell cul-
tures relative to mock-infected T98G cells (B) and virus 
induced PARP cleavage (MOI 1) (C) in infected cells. Values 
represent the mean (± SD) of three different experiments 
and pictures shown are representative for a set of three dif-
ferent experiments. *p < 0.05 compared to mock-infected 
cultures.BMC Microbiology 2007, 7:49 http://www.biomedcentral.com/1471-2180/7/49
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cultures (MOI 0.1) treated with 0, 25, 50 and 100 µM z-
VAD-fmk were compared. Caspase inhibition had no
effect on infectious virus titres at 48 h p.i. (Fig. 5b).
Discussion
The human glioma cell line T98G is permissive for WNV
infection as demonstrated by the production of infectious
virus and viral antigens. In the present study, we used this
cell culture system to study effects of WNV infection on
apoptosis induction in brain-derived cells. WNV infection
killed T98G cells in a time dependent manner. Although
maximum virus titre was achieved 48 h p.i., WNV proteins
continued to accumulate in infected cells at later times.
The accumulation of viral proteins correlated with
decreasing cell viability and the level of observed cyto-
pathic effects. Similar observation demonstrating that the
induction of cell death can happen independently of
WNV-replication were made before using other cell types
including human kidney cell line 293 and human retinal
pigment epithelial cells [17,18]. Taken together, these
data suggest that the treatment with inhibitors of virus
replication at later time points p.i. may be limited in pre-
venting WNV-induced pathogenicity. Therefore, sub-
stances that inhibit WNV-induced cytotoxic effects may be
used as additional treatment options in the therapy of
WNV diseases to improve outcome.
Many viruses including WNV have been shown to induce
apoptosis in their target cells in vitro and in vivo [6,19-
21]. Activation of both the intrinsic and extrinsic apop-
totic pathways has been described during viral infections.
The extrinsic apoptotic pathway is initiated by binding of
death activators (e.g. Fas-ligand) to their respective trans-
Caspase inhibitor peptides inhibit WNV-induced PARP-cleav- age Figure 4
Caspase inhibitor peptides inhibit WNV-induced PARP-cleav-
age. Effect on WNV-induced PARP cleavage of peptides z-
IETD-fmk (caspase-8 inhibitor), z-LEHD-fmk (caspase-9 
inhibitor) and z-VAD-fmk (pancaspase inhibitor) at 48 h p.i. 
Results are expressed as percentage of values obtained from 
WNV-infected cultures (MOI 1) without any inhibitor added. 
Values represent mean (± SD) from three independent 
experiments. *p < 0.05 compared to untreated virus control.
WNV infection induces caspase activation and cytochrome c  release Figure 3
WNV infection induces caspase activation and cytochrome c 
release. Cellular levels of procaspase-8, cleaved caspase-9, 
BID and procaspase-3 during WNV-infection (A), release of 
cytochrome c from mitochondria into the cytoplasma (B) 
and caspase-3 activation (C) in WNV infected cells (all MOI 
1). The band in A marked with * resulted from unspecific 
antibody binding. Blots shown are representative for a set of 
three different experiments. Values represent mean (± SD) 
from three independent experiments. *p < 0.05 compared to 
mock-infected cultures.BMC Microbiology 2007, 7:49 http://www.biomedcentral.com/1471-2180/7/49
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membrane death receptors. This binding allows interac-
tion with cytoplasmatic adaptor proteins (e.g. Fas
associated death domain) which subsequently activates
caspase-8. The activation of caspase-8 leads to effector cas-
pases (e.g. caspase-3 or -7) activation and the degradation
phase of apoptosis [22]. The intrinsic apoptotic pathway
is initiated by signalling from pro-apoptotic proteins of
the Bcl-2 family such as Bax which trigger mitochondria-
outer-membrane-permeabilisation (MOMP) followed by
the release of cytochrome c from mitochondria into the
cytoplasma in the induction phase. Cytochrome c then
associates with Apaf-1, caspase-9, and ATP to form the
apoptosome. The apoptosome, similar to caspase-8 then
induces the degradation phase of apoptosis via activation
of effector caspases [4]. These pathways cross-interact
rather than being single linear mechanisms. It has been
suggested that cleavage of BID by caspase-8 can induce
MOMP with subsequent release of cytochrome c into the
cytoplasma [23].
WNV infection induces apoptosis in different cell types
under involvement of components of the intrinsic and
extrinsic apoptotic pathways. WNV infection as well as
gene delivery of WNV capsid into the monkey kidney cell
line Vero, induced apoptosis through a mitochondrial-
based caspase-9 pathway [5,8]. In mouse neuroblastoma
cell line Neuro-2a, WNV infection induced upregulation
of bax gene expression [6]. Moreover, the WNV NS3
induced host cell apoptotic pathways involving caspase-8
and -3 in different cell types [7]. Recently, aspects of WNV-
induced apoptosis in neural cells were studied in wild-
type and caspase-3-/-  mice and primary CNS-derived
mouse neurons [11]. Caspase-3 activation and DNA-frag-
mentation were demonstrated in brains of infected ani-
mals and in neuronal cultures. It was shown that, caspase-
3 deficiency significantly decreased WNV-induced death
of treated animals. Our results are in concert with these
findings, demonstrating that our culture system may be
useful to study virus-induced cell death in neuronal cells.
In contrast to this recently published report [11], we also
evaluated the apoptotic-pathways upstream of caspase-3
activation. Our data reveal that WNV infection induces
caspase-8, -9 and -3 activation, PARP cleavage, MOMP, as
indicated by cytochrome c release from the mitochondria,
and cell death in T98G cells. The induction of apoptosis
in T98G cells was replication-dependent as UV-inacti-
vated virus did not induce death of treated cells. The
WNV-induced PARP cleavage in T98G cells was strongly
inhibited by the use of a pan-caspase inhibitor. Further-
more, inhibition of caspase activity inhibited virus-
induced cell killing without affecting virus replication.
This demonstrates that WNV-induced apoptosis plays a
significant role in WNV-induced death of T98G cells.
WNV infection induced cleavage of the effector caspase-3
and the initiator caspases-8 and -9, suggesting contribu-
tion of both, the extrinsic and the intrinsic apoptotic path-
ways to WNV-induced apoptosis. In concordance,
inhibition of caspase-8 as well as inhibition of caspase-9
significantly inhibited WNV-induced PARP cleavage. BID
truncation/activation in WNV-infected T98G cells sug-
gests cross-talk between the extrinsic and the intrinsic cas-
pase pathways.
Inhibition of host cell apoptosis may improve outcome
with or without affecting virus replication in different
viral diseases. Two broad-spectrum caspase inhibitors
were shown to inhibit reovirus-induced myocardial
pathogenesis and to improve survival in mice, without
Prevention of WNV-induced cell death by pan-caspase inhibi- tion Figure 5
Prevention of WNV-induced cell death by pan-caspase inhibi-
tion. Inhibition of virus-induced cell death indicated by trypan 
blue staining of WNV (MOI 0.1)-infected T98G cell cultures 
by pan-caspase inhibitor z-VAD-fmk (100 µM) relative to 
mock-infected cells (A) and the effect of different z-VAD-fmk 
concentrations on infectious virus titre production (TCID50/
ml, 48 h p.i.) after infection at MOI 0.1 (B). Values represent 
mean (± SD) from three independent experiments. *p < 0.05 
compared to untreated virus control.BMC Microbiology 2007, 7:49 http://www.biomedcentral.com/1471-2180/7/49
Page 6 of 8
(page number not for citation purposes)
exerting inhibitory effects on virus replication [24]. Cox-
sackievirus B3 induced apoptosis and cytopathic effects
were prevented by inhibition of glycogen synthase kinase
3 beta (GSK3β) in cell culture [25]. Apoptosis inhibition
also prevented cytopathic effects of flaviviruses. A pancas-
pase inhibitor prevented JEV apoptosis in murine (N18)
and human (NT-2) neuronal cell lines [26]. Treatment of
N18 cells with dehydroepiandrosterone suppressed JEV-
induced cytopathic effects and JEV-induced apoptotic cell
death without influencing virus replication [27]. Moreo-
ver, in vitro treatment of primary neurons with IFN-ß
either before or after infection increased neuronal survival
independently of its effects on WNV replication [28],
demonstrating that neuroprotective agents might be use-
ful to prevent WNV induced neural damage. However, cell
death in vivo is much more complex and involves multi-
ple regulators. To underscore a need for detailed studies of
apoptosis it should be noted that there are recent studies
showing that apoptotic cells may induce apoptosis in
neighbouring healthy cells through bystander-mediated
events [29,30]. This possibility has not been ruled out in
the WNV infected brain.
Conclusion
We found that WNV infection induces cell death in the
brain-derived tumour cell line T98G by apoptosis under
involvement of constituents of the extrinsic as well as the
intrinsic apoptotic pathways. Pan-caspase inhibition pre-
vented WNV-induced PARP cleavage as well as cell death
without affecting virus replication. Our results illuminate
the molecular mechanism of WNV-induced neural cell
death.
Methods
Materials
Caspase inhibitor peptides z-lle-Glu(OMe)-Thr-
Asp(OMe)-FMK (z-IETD-fmk), z-Leu-Glu(OMe)-His-Asp-
(OMe)-FMK (z-LEHD-fmk) (Calbiochem, Darmstadt,
Germany) and benzyloxycarbonyl-Val-Ala-Aspfluor-
omethylketon (z-VAD-fmk) (R&D Systems, Wiesbaden,
Germany) directed against the active forms of caspase-8,
caspase-9 and pan-caspase, respectively, were dissolved in
dimethylsulfoxide (DMSO) at stock concentrations of
100 µM and stored at -20°C until use. They were added
directly to culture medium at concentrations ranging from
6.25 to 100 µM. The concentration of DMSO did not
exceed 0.1% (v/v) of total culture medium volume
throughout all experiments.
Cell cultures
T98G cells, derived from a patient with glioma and vero
cells (monkey kidney cell line) were obtained from the
American Type Culture Collection (ATCC, Rockville,
MD). T98G cells were grown at 37°C in Iscove's modified
Dulbecco's medium (IMDM) supplemented with 10%
heat-inactivated fetal calf serum (FCS) and containing
100 IU/ml of penicillin and 100 µg/ml streptomycin. Vero
cells were cultured in minimum essential medium (MEM)
supplemented with 10%FCS and containing 100 IU/ml of
penicillin and 100 µg/ml streptomycin.
Virus preparation
WNV strain NY385-99, which was used throughout all
experiments, was kindly provided by Dr. J. ter Meulen
(Institut für Virologie, Phillips-Universität, Marburg, Ger-
many). The strain was originally isolated from a snowy
owl that died at the Bronx Zoo during the 1999 epizootic
in New York City [13]. Virus was propagated on Vero cells
and stocks were stored at -80°C. Virus titres were deter-
mined as 50% tissue culture infectious dose (TCID50/ml)
in Vero cell monolayer in 96-well microtitre plates. For
viral infection cells were incubated with virus at multiplic-
ity of infection (MOI) 0.1 and 1.
WNV was inactivated by UV exposure (254 nm) for 20
min at a distance of 5 cm. Inactivation was confirmed by
infection experiments on T98G and Vero cells.
In accordance with WHO recommendations, all work
involving infectious WNV was performed under bio-safety
level (BSL)-3 conditions.
Cell viability assay
To assess effects of WNV infection on T98G cell viability
confluent cell layers in 96-well microtitre plates were
infected at MOI 0.1 and 1. The viability was measured at
different time points post infection (p.i.) using the 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) assay method as described previously [14].
To assess the effects of z-VAD-fmk on cell viability of
WNV-infected T98G cell cultures, the viability was meas-
ured using the trypan blue dye exclusion method. For this
purpose, cells were washed twice with PBS and then
trypsinised to gain a homogeneous cell suspension. Sub-
sequently, 20 µl cell suspension was added to 80 µl of
trypan blue vital staining dye. Following an incubation
period of 2 min the amount of viable cells was determined
by use of an inverted light microscope.
Immune staining
Virus envelope-antigen, activated caspase-3 and the 85kD
fragment of cleaved PARP were detected by immune-
staining. The following primary antibodies were used:
WNV-E1 (Chemicon, Hofheim Germany), caspase-3
(active) (R&D Systems, Wiesbaden, Germany) and PARP
p85-fragment (Promega, Mannheim, Germany). Biotin-
conjugated secondary monoclonal antibodies were used
and visualisation was performed with streptavidin-perox-
idase complex with AEC as a substrate.BMC Microbiology 2007, 7:49 http://www.biomedcentral.com/1471-2180/7/49
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Western Blotting
Cell lysates were subjected to SDS-PAGE before transfer to
nitrocellulose membranes (Schleicher & Schuell, Dassel,
Germany) using the Mini-Protean II system (Bio-Rad,
Munich, Germany). After transfer, blots were blocked in
TBS containing 5% skimmed milk for 1 h to saturate the
non-specific protein-binding sites on the nitrocellulose
membrane. The following primary antibodies were used:
WNV E1 (Chemicon, Hofheim, Germany), caspase-9
(kindly provided by Dr. Martin Zörnig, Frankfurt/Main,
Germany), caspase-8 (Cell Signalling, Beverly, MA), BID
(BioVision, Palo Alto, CA) and caspase-3 (Upstate, Char-
lottesville, VA). The blot was incubated with the primary
antibody diluted in TBS overnight at 4°C with gentle agi-
tation. Following a 1 h incubation period with peroxi-
dase-conjugated secondary antibody at room temperature
visualisation was performed by enhanced chemilumines-
cence using a commercially available kit (Amersham, Liv-
erpool, UK).
Cytochrome-c release
The cytochrome c release from mitochondria was detected
by flow cytometry as previously described [15,16]. Briefly,
mock infected and WNV infected (MOI 1) cells were har-
vested, washed with cold PBS, pelleted, and permeabilised
so that cytochrome c, released from the mitochondria in
apoptotic cells, could be washed away. Upon fixation
with 3.7% formaldehyde, cells were incubated for 1 h at
room temperature with blocking buffer (0.05% saponin,
3% BSA in PBS) followed by incubation overnight at 4°C
with primary anti-cytochrome c antibody (BD Pharmin-
gen, Heidelberg, Germany). After incubation with second-
ary FITC-labelled anti-mouse antibody for 40 min on ice,
the percentage of non-apoptotic cells containing mito-
chondrial cytochrome c was quantified.
Statistics
Results are mean ± S.D. of at least three independent
experiments and images shown are representative for a set
of three independent experiments. Student's t-test was
performed to calculate significance with p values < 0.05
considered to be significant.
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